Laura L. Johnson is Director of LA JOLLA PHARMACEUTICAL CO. Currently has a direct ownership of 0 shares of LJPC, which is worth approximately $0. The most recent transaction as insider was on Aug 22, 2022, when has been sold 500 shares (Common Stock) at a price of $6.23 per share, resulting in proceeds of $3,115. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Laura L. Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2022
SELL
Sale (or disposition) back to the issuer
$3,115 $6.23 p/Share
500 Reduced 100.0%
0 Common Stock

Also insider at

ODTC
Odonate Therapeutics, Inc. Financial Services
KTRA
Kintara Therapeutics, Inc. Healthcare
LLJ

Laura L. Johnson

Director
San Diego, CA

Track Institutional and Insider Activities on LJPC

Follow LA JOLLA PHARMACEUTICAL CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LJPC shares.

Notify only if

Insider Trading

Get notified when an La Jolla Pharmaceutical CO insider buys or sells LJPC shares.

Notify only if

News

Receive news related to LA JOLLA PHARMACEUTICAL CO

Track Activities on LJPC